Aurobindo Pharma stock moves in trade ahead of the approval of transfer of its Unit 4 facility by the board, to Eugla Pharma Specialties which is a wholly-owned subsidiary of the company. The company is also looking to consolidate its injectables business under one umbrella. Here are more details.
#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #AurobindoPharma
CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.
For latest news and updates visit our Website: [ Ссылка ]
Subscribe to our Channel: [ Ссылка ]
Like us on Facebook: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
